hepatitis B immune globulin (HBIg)

BIOLOGICAL2 trials

Sponsors

Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA), National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Conditions

Chronic Hepatitis BHepatitis BLiver Transplantation

Phase 2

HepeX-B in Post Hepatic Allografts for Treatment of End Stage Liver Disease Due to Hepatitis B Infection

TerminatedNCT00228592

Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)Hepatitis B, Liver Transplantation

End: 2005-08-31Updated: 2007-02-13

Hepatitis B Immune Globulin (HBIg) to Restore Immune Control in People With Chronic Hepatitis B

WithdrawnNCT03575208

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Chronic Hepatitis B

Start: 2019-02-13End: 2022-03-29Updated: 2022-04-06